Innate Pharma has an alternative to T cell-based immunotherapy that has the potential to quickly and safely eradicate solid and metastatic tumors in the body. The caveat is that the work has, as yet, advanced only to non-human primates. With IND-enabling studies being conducted by Innate’s partner, Sanofi, the start of human clinical trials seems […]

Cartesian Therapeutics President & Chief Executive Officer, Murat Kalayoglu, MD, PhD, Returns to BioTalk to provide an update since his last visit on their cell and gene therapies, as well as fundraising successes.

When Pete Mariani joined Axogen in early 2016 as its CFO, the company’s products were making a difference in the lives of people with nerve damage, but it was under-capitalized and lacked a sizable investor base. The reason was bad timing. Back in 2007, just as it was considering going public to capitalize on the release […]